04/25/2024 3:30 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form DEF 14A | |
04/25/2024 3:35 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form DEFA14A | |
04/12/2024 7:08 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/12/2024 3:23 PM | Patel Sushil (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:21 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024 3:21 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024 3:21 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
04/10/2024 3:21 PM | Patel Sushil (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/29/2024 3:57 PM | Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer) Wei Lin (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/27/2024 3:24 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024 3:43 PM | Anders Jack (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 3:44 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 3:44 PM | Horn Margaret A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 3:45 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 3:45 PM | Cislini Jeff (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 4:50 PM | Horn Margaret A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 4:10 PM | Anders Jack (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 4:21 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 4:04 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 3:48 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024 3:32 PM | Horn Margaret A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 3:30 PM | Horn Margaret A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 3:52 PM | Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer) Wang Xiaolin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 3:53 PM | Anders Jack (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 3:54 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 3:54 PM | Cislini Jeff (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 3:55 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:30 PM | EcoR1 Capital, LLC (Filed by) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form SC 13G/A | |
02/14/2024 8:26 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form SC 13G/A | |
02/13/2024 5:06 AM | BB BIOTECH AG (Filed by) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form SC 13G/A | |
02/12/2024 4:11 PM | Farallon Capital Partners, L.P. (Filed by) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form SC 13G/A | |
02/09/2024 4:22 PM | COLUMN GROUP III, LP (Filed by) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form SC 13G/A | |
02/08/2024 9:17 AM | Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/22/2024 3:18 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2024 3:26 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 1:15 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 3:06 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:31 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/29/2023 3:14 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2023 3:22 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023 4:07 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad) The latest flare-up between Israel and Palestinian militants has sent gold prices surging.
Why? Because savvy investors know the endgame of the elites at play…
Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
See why the elites are pouring billions into gold. |
12/20/2023 4:08 PM | Cislini Jeff (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 4:08 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 4:10 PM | Anders Jack (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 6:30 PM | Horn Margaret A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 3:35 PM | Horn Margaret A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023 5:38 PM | Horn Margaret A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144/A | |
12/14/2023 4:55 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023 5:14 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023 5:22 PM | Anders Jack (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023 4:48 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023 4:37 PM | Horn Margaret A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023 3:33 PM | Horn Margaret A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/20/2023 5:24 PM | Cislini Jeff (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 3:14 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023 1:58 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form CERT | |
11/15/2023 3:04 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 8-A12B | |
11/14/2023 7:13 PM | Horning Sandra (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
11/14/2023 7:13 PM | Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer) Schroeder Thilo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2023 7:14 PM | Borisy Alexis (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2023 7:15 PM | Horning Sandra (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/09/2023 4:18 PM | Farallon Capital Partners, L.P. (Filed by) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form SC 13G | |
11/09/2023 12:26 PM | Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/09/2023 8:20 AM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2023 3:05 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2023 3:09 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/01/2023 6:11 AM | Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 425 | |
11/01/2023 6:15 AM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form DEFA14A | |
11/01/2023 6:08 AM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/25/2023 5:20 PM | Horn Margaret A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/24/2023 6:21 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/23/2023 5:01 PM | Anders Jack (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/23/2023 5:11 AM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/23/2023 5:13 AM | EQRx, Inc. (Subject) EQRx, Inc. (Subject) EQRx, Inc. (Subject) EQRx, Inc. (Subject) Revolution Medicines (Filed by) Revolution Medicines, Inc. (Filed by)
| Form 425 | |
10/18/2023 3:23 PM | Horn Margaret A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2023 3:19 PM | Horn Margaret A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/13/2023 3:20 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/13/2023 10:54 AM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/11/2023 3:05 PM | Kelsey Stephen Michael (Reporting) Kelsey Stephen Michael (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2023 3:12 PM | Cislini Jeff (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/01/2023 11:15 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form EFFECT | |
09/29/2023 3:19 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form DEFM14A | |
09/29/2023 3:19 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form DEFM14A | |
09/29/2023 3:17 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 424B3 | |
09/28/2023 3:10 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2023 4:25 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form S-4/A | |
09/20/2023 3:12 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2023 3:13 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2023 3:11 PM | Anders Jack (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2023 3:11 PM | Cislini Jeff (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2023 11:40 AM | Horn Margaret A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad) The latest flare-up between Israel and Palestinian militants has sent gold prices surging.
Why? Because savvy investors know the endgame of the elites at play…
Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
See why the elites are pouring billions into gold. |
09/19/2023 8:41 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2023 8:44 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2023 8:24 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2023 8:12 PM | Anders Jack (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2023 3:17 PM | Horn Margaret A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/15/2023 3:23 PM | Horn Margaret A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023 4:20 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form S-4 Registration statement under Securities Act of 1933 | |
09/06/2023 7:02 PM | Anders Jack (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 7:03 PM | Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer) Weber Barbara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |